SCHEMBL1991694

SCHEMBL1991694

CCCCCOC(=O)c1ccc(C(=O)O)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.71
MAPT P10636 1/20 0.71
RAB9A P51151 1/20 0.71
ALDH1A1 P00352 1/20 0.71
TSHR P16473 4/20 0.67
LMNA P02545 2/20 0.67
CYP1A2 P05177 2/20 0.67
CYP2C19 P33261 2/20 0.67
MAPK1 P28482 2/20 0.67
ESR1 P03372 1/20 0.67
CYP2D6 P10635 1/20 0.67
NR1H2 P55055 1/20 0.67
RNASEL Q05823 1/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
TP53 P04637 2/20 0.65
CYP3A4 P08684 2/20 0.65
CYP2C9 P11712 1/20 0.65
PDE4D Q08499 1/20 0.65
PLA2G4B P0C869 1/20 0.63
STS P08842 6/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31228853 0.98 ALDH1A1 (0.73) NPC1MAPTRAB9AALDH1A1TSHR
SCHEMBL9244917 0.98 ALDH1A1 (0.73) NPC1MAPTRAB9AALDH1A1TSHR
SCHEMBL2918094 0.98 ALDH1A1 (0.73) NPC1MAPTRAB9AALDH1A1TSHR
SCHEMBL1993625 0.98 ALDH1A1 (0.73) NPC1MAPTRAB9AALDH1A1TSHR
SCHEMBL2534845 0.98 ALDH1A1 (0.73) NPC1MAPTRAB9AALDH1A1TSHR
SCHEMBL108533 0.98 ALDH1A1 (0.73) NPC1MAPTRAB9AALDH1A1TSHR
Ammonia Solution, Strong SCHEMBL20240889 0.98 NPC1 (0.69) NPC1MAPTRAB9AALDH1A1TSHR
SCHEMBL3665530 0.98 ALDH1A1 (0.73) NPC1MAPTRAB9AALDH1A1TSHR
SCHEMBL6670415 0.98 ALDH1A1 (0.73) NPC1MAPTRAB9AALDH1A1TSHR
SCHEMBL29918655 0.98 ALDH1A1 (0.73) NPC1MAPTRAB9AALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120020114-A Preparation method of N-alkenyl amide compound 中国石油化工股份有限公司 2025-05-20 CN claimed
CN-120020115-A Process for the preparation of N- (alkyl-2-hydroxy) alkylamides and N-alkenylamides 中国石油化工股份有限公司 2025-05-20 CN claimed
CN-118234804-A Heat resistant thermoplastic electrostatic dissipative compositions 科思创德国股份有限公司 2024-06-21 CN claimed
US-11932749-B2 Plasticizer composition comprising tripentyl esters of 1,2,4-cyclohexanetricarboxylic acid EVONIK OXENO GMBH & CO. KG (DE) 2024-03-19 US claimed
US-20220411604-A1 Plasticizer composition comprising tripentyl esters of 1,2,4-cyclohexanetricarboxylic acid EVONIK OPERATIONS GMBH (DE) 2022-12-29 US claimed
EP-4105272-A1 SOFTENING COMPOSITION COMPRISING TRIPENTYL ESTER OF 1,2,4-CYCLOHEXANTRICARBOXYLIC ACID Evonik Operations GmbH (DE) 2022-12-21 EP claimed
CN-115477787-A Plasticizer composition comprising tripentyl ester of 1,2, 4-cyclohexanetricarboxylic acid 赢创运营有限公司 2022-12-16 CN claimed
EP-4279532-B1 CROSSLINKED POLYGLYCEROL PARTIAL ESTERS EVONIK OPERATIONS GMBH (DE) 2026-03-25 EP disclosed
US-12577373-B2 Carbodiimide composition, curing agent composition, coating composition and resin cured product ASAHI KASEI KABUSHIKI KAISHA (JP) 2026-03-17 US disclosed
EP-4279531-B1 CROSSLINKED POLYGLYCEROL ESTERS EVONIK OPERATIONS GMBH (DE) 2026-02-25 EP disclosed
US-20250230118-A1 TWO-STAGE PROCESS FOR PRODUCING TETRAALKYL 1,2,3,4 BUTANETETRACARBOXYLATES EVONIK OXENO GMBH & CO. KG (DE) 2025-07-17 US disclosed
EP-4577645-A1 ENZYME VARIANTS AND USES THEREOF Samsara Eco Pty Limited (AU) 2025-07-02 EP disclosed
CN-120051566-A Enzyme variants and uses thereof 杉萨拉生态私人有限公司 2025-05-27 CN disclosed
EP-0636064-A4 LENSES WITH HIGH IMPACT RESISTANCE AND HIGH SCRATCH RESISTANCE. SOANE TECHNOLOGIES INC (US) 1998-07-01 EP disclosed
EP-0636064-A1 LENSES WITH HIGH IMPACT RESISTANCE AND HIGH SCRATCH RESISTANCE SOANE TECHNOLOGIES INC. (US) 1995-02-01 EP disclosed
WO-1993021010-A1 LENSES WITH HIGH IMPACT RESISTANCE AND HIGH SCRATCH RESISTANCE SOANE TECHNOLOGIES, INC. (US) 1993-10-28 WO disclosed
EP-0369734-A2 Improving the thermal properties of a polyalkyleneterephthalate without significant loss of physical and low temperature properties AMOCO CORPORATION (US) 1990-05-23 EP disclosed
EP-0096906-B1 HEAT-CURABLE EPOXY COMPOSITIONS AND THEIR USE IN PREPARING FORMED ARTICLES SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1986-04-02 EP disclosed
US-4508779-A POLYESTERIMIDE COATINGS SUMITOMO ELECTRIC INDUSTRIES, LTD. (JP) 1985-04-02 US disclosed
US-4196279-A BORANE OR METAL TETRAHYDROCARBYLBORON TEIJIN LIMITED (JP) 1980-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250230118-A1 TWO-STAGE PROCESS FOR PRODUCING TETRAALKYL 1,2,3,4 BUTANETETRACARBOXYLATES ADH1A, ADH1C, TBCA NPC1 2055/4885MAPT 1613/4885RAB9A 3411/4885
US-12577373-B2 Carbodiimide composition, curing agent composition, coating composition and resin cured product CD38, PARP9, MCCC2 NPC1 4413/4885MAPT 486/4885RAB9A 2004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.